Medication Overuse Headache (MOH) results from the chronicisation of primary forms of headaches, as a consequence of the progressive increase in the intake of symptomatic drugs. The first choice treatment for MOH is the withdrawal of the overused medication(s) (detoxification), which is preferentially done by hospitalising the patients. Even if most patients improve as a result of detoxification, up to 45% of patients relapse, reverting to the overuse of symptomatic drugs.
Paper diaries and calendars for recording headache attacks have long been used in the clinical practice for the management of headache patients. Isolated attempts to electronically record headache attacks have also been performed, based on the use of single common files.
At present, however, there is no scientifically validated informative tool that could manage patient's treatment, from the first observation to the whole follow-up. The availability of such a tool would grant an innovative approach to MOH.
Objectives of the project and project description
The general objective of the COMOESTAS project is to improve and integrate the management of MOH with an innovative electronic tool that makes the patient himself a key node in the treatment process. The new system, will be based on a complex informative system called Interactive Electronic Patient Record (IEPR) and will constitute an "all-inone" solution that will allow constant monitoring of the clinical condition of the patient by the doctor and provide a system of alerts and warnings should selected parameters exceed given thresholds. The system will also be designed in order to improve the patientdoctor communication.
Expected Results and Impacts
The constant monitoring by means of the electronic diary and programmed or alertprompted follow-up visits permit and favour a better interaction between patient and physician in order to ameliorate the management of these patients after the withdrawal. Furthermore, this will increase patient safety by optimising medical interventions, preventing errors and reducing drug-induced side effects (i.e. gastritis, hypertension). As a consequence, direct (consultations, hospitalisations, etc.) and indirect (i.e. linked to the disability and complications caused by the disease) costs provoked by the condition will be reduced.
Work in progress
- The kick-off meeting took place in Pavia, on February 14-16
- Indicators, clinical protocol and clinical tools have been devised, and will be finalised in April
- The beta version of the IEPR system will be ready for pilot testing by the end of May
- Clinical centres in Argentina and Chile are collecting data on the epidemiological impact of MOH in Latin America
For further information, please visit:
http://www.comoestas-project.eu
Related article:
- FP7 eHealth Projects: COMOESTAS